ReviewClinical trials (London, England)2025

Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.

Yunda Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.